Astra, Sanofi's antibody 90% effective against RSV in infants - CDC
(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday. Read More